We acknowledge the importance of including female mice to fully understand the therapeutic potential of hydroxyl-dendrimer-GLS1 inhibitor conjugates, as sex differences can influence the pathophysiology and treatment outcomes of depression. Here, GLS is linked to depressive symptom measurement.